|
Volumn 24, Issue 1 SUPPL. 4, 1997, Pages
|
Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alfa and chemotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
DACARBAZINE;
RECOMBINANT ALPHA INTERFERON;
RECOMBINANT INTERLEUKIN 2;
TAMOXIFEN;
VINBLASTINE;
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
CVD PROTOCOL;
CYCLOPHOSPHAMIDE;
INTERLEUKIN 2;
VINCRISTINE;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MELANOMA;
METASTASIS;
NEUTROPENIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
SKIN TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
HUMANS;
INTERFERON-ALPHA;
INTERLEUKIN-2;
MELANOMA;
NEOPLASM METASTASIS;
SKIN NEOPLASMS;
VINCRISTINE;
|
EID: 0030937204
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (63)
|
References (25)
|